Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder

Biological Psychiatry

Volumn 81, Issue 5, 2017, Pages 442-451

  Krakowiak, Paula ^a,b   Goines, Paula E ^b   Tancredi, Daniel J ^b   Ashwood, Paul ^b   Hansen, Robin L ^b   Hertz Picciotto, Irva ^a,b   Van de Water, Judy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder; Blood spot; Chemokines; Developmental delays; Neonatal cytokines; Neurodevelopment

Indexed keywords

CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

ARTICLE; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; BEHAVIOR DISORDER; CHILD BEHAVIOR CHECKLIST; COGNITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRIED BLOOD SPOT TESTING; FEMALE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NEWBORN; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; AUTISM SPECTRUM DISORDER; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

AUTISM SPECTRUM DISORDER; BIOMARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-4; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84942048291     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.08.007     Document Type: Article

References (67)

1. 1 Lord, C., Cook, E.H., Leventhal, B.L., Amaral, D.G., Autism spectrum disorders. Neuron 28 (2000), 355–363.
2. 2 World Heath Organization (2006): International Statistical Classification of Diseases and Related Health Problems (ICD-10). 10th ed.
3. 3 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed (DSM-5), 2013, American Psychiatric Association, Arlington, VA.
4. 4 Herbert, M.R., Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol 23 (2010), 103–110.
5. 5 Le Couteur, A., Haden, G., Hammal, D., McConachie, H., Diagnosing autism spectrum disorders in pre-school children using two standardised assessment instruments: The ADI-R and the ADOS. J Autism Dev Disord 38 (2008), 362–372.
6. 6 Lord, C., Risi, S., Lambrecht, L., Cook, E.H. Jr, Leventhal, B.L., DiLavore, P.C., et al. The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000), 205–223.
7. 7 Lord, C., Rutter, M., Le Couteur, A., Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994), 659–685.
8. 8 Dawson, G., Jones, E.J., Merkle, K., Venema, K., Lowy, R., Faja, S., et al. Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry 51 (2012), 1150–1159.
9. 9 Goines, P., Croen, L.A., Braunschweig, D., Yoshida, C., Grether, J., Hansen, R., et al. Increased mid-gestational IFN-γ, IL-4, and IL-5 in women giving birth to a child with autism: A case-control study. Mol Autism, 2, 2011, 13.
10. 10 Croen, L.A., Braunschweig, D., Haapanen, L., Yoshida, C.K., Fireman, B., Grether, J.K., et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: The early markers for autism study. Biol Psychiatry 64 (2008), 583–588.
11. 11 Careaga, M., Van de Water, J., Ashwood, P., Immune dysfunction in autism: A pathway to treatment. Neurotherapeutics 7 (2010), 283–292.
12. 12 Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., Van de Water, J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25 (2011), 40–45.
13. 13 Onore, C., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Van de Water, J., et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol 216 (2009), 126–129.
14. 14 Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D., Van de Water, J., Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci 1107 (2007), 79–91.
15. 15 Goines, P., Haapanen, L., Boyce, R., Duncanson, P., Braunschweig, D., Delwiche, L., et al. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 25 (2011), 514–523.
16. 16 Singer, H.S., Morris, C.M., Williams, P.N., Yoon, D.Y., Hong, J.J., Zimmerman, A.W., Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 178 (2006), 149–155.
17. 17 Goines, P.E., Ashwood, P., Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment. Neurotoxicol Teratol 36 (2013), 67–81.
18. 18 Abdallah, M.W., Larsen, N., Grove, J., Bonefeld-Jorgensen, E.C., Norgaard-Pedersen, B., Hougaard, D.M., et al. Neonatal chemokine levels and risk of autism spectrum disorders: Findings from a Danish historic birth cohort follow-up study. Cytokine 61 (2013), 370–376.
19. 19 Abdallah, M.W., Larsen, N., Mortensen, E.L., Atladottir, H.O., Norgaard-Pedersen, B., Bonefeld-Jorgensen, E.C., et al. Neonatal levels of cytokines and risk of autism spectrum disorders: An exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J Neuroimmunol 252 (2012), 75–82.
20. 20 Zerbo, O., Yoshida, C., Grether, J.K., Van de Water, J., Ashwood, P., Delorenze, G.N., et al. Neonatal cytokines and chemokines and risk of autism spectrum disorder: The Early Markers for Autism (EMA) study: A case-control study. J Neuroinflammation, 11, 2014, 113.
21. 21 Hertz-Picciotto, I., Croen, L.A., Hansen, R., Jones, C.R., Van de Water, J., Pessah, I.N., The CHARGE study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114 (2006), 1119–1125.
22. 22 Mullen, E.M., Mullen Scales of Early Early Learning. 1995, American Guidance Service, Inc., Circle Pines, MN.
23. 23 Sparrow, S.S., Balla, D.A., Cicchetti, D.V., Vineland Adaptive Behavior Scales Interview Edition Expanded from Manual. 1984, American Guidance Service, Inc., Circle Pines, MN.
24. 24 Le Couteur, A., Lord, C., Rutter, M., Autism Diagnostic Interview–Revised (ADI-R). 2003, Western Psychological Services, Los Angeles, CA.
25. 25 Lord, C., Rutter, M., DiLavore, P.C., Risi, S., Gotham, K., Bishop, S.L., Autism Diagnostic Observation Schedule. Second Edition (ADOS-2), 2012, Western Psychological Services, Los Angeles, CA.
26. 26 Risi, S., Lord, C., Gotham, K., Corsello, C., Chrysler, C., Szatmari, P., et al. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 45 (2006), 1094–1103.
27. 27 Rutter, M., Bailey, A., Berument, S.K., Lord, C., Pickles, A., Social Communication Questionnaire (SCQ). 2003, Western Psychological Services, Los Angeles, CA.
28. 28 Aman, M.G., Singh, N.N., Aberrant Behavior Checklist—Community. 1994, Slosson Educational Publications, East Aurora, NY.
29. 29 Kharrazi, M., Pearl, M., Yang, J., DeLorenze, G.N., Bean, C.J., Callaghan, W.M., et al. California Very Preterm Birth Study: Design and characteristics of the population- and biospecimen bank-based nested case-control study. Paediatr Perinat Epidemiol 26 (2012), 250–263.
30. 30 Kabacoff RI (2003): Determining the dimensionality of data: A SAS macro for parallel analysis. In: SAS Institute Inc. Proceedings of the Twenty Eighth Annual SAS Users Group International (SUGI 28). Cary, NC: SAS Institute Inc.
31. 31 Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B 57 (1995), 289–300.
32. 32 Jaspan, H.B., Lawn, S.D., Safrit, J.T., Bekker, L.G., The maturing immune system: Implications for development and testing HIV-1 vaccines for children and adolescents. AIDS 20 (2006), 483–494.
33. 33 Zaretsky, M.V., Alexander, J.M., Byrd, W., Bawdon, R.E., Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103 (2004), 546–550.
34. 34 Gregor, H., Egarter, C., Levin, D., Sternberger, B., Heinze, G., Leitich, H., et al. The passage of granulocyte-macrophage colony-stimulating factor across the human placenta perfused in vitro. J Soc Gynecol Investig 6 (1999), 307–310.
35. 35 Skogstrand, K., Thorsen, P., Norgaard-Pedersen, B., Schendel, D.E., Sorensen, L.C., Hougaard, D.M., Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51 (2005), 1854–1866.
36. 36 Skogstrand, K., Ekelund, C.K., Thorsen, P., Vogel, I., Jacobsson, B., Norgaard-Pedersen, B., et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 336 (2008), 78–84.
37. 37 Eising, S., Svensson, J., Skogstrand, K., Nilsson, A., Lynch, K., Andersen, P.S., et al. Type 1 diabetes risk analysis on dried blood spot samples from population-based newborns: Design and feasibility of an unselected case-control study. Paediatr Perinat Epidemiol 21 (2007), 507–517.
38. 38 Neto, E.C., Rubin, R., Schulte, J., Giugliani, R., Newborn screening for congenital infectious diseases. Emerg Infect Dis 10 (2004), 1068–1073.
39. 39 Nelson, P.G., Kuddo, T., Song, E.Y., Dambrosia, J.M., Kohler, S., Satyanarayana, G., et al. Selected neurotrophins, neuropeptides, and cytokines: Developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int J Dev Neurosci 24 (2006), 73–80.
40. 40 Lovett-Racke, A.E., Smith, M.E., Arredondo, L.R., Bittner, P.S., Ratts, R.B., Shive, C.L., et al. Developmentally regulated gene expression of Th2 cytokines in the brain. Brain Res 870 (2000), 27–35.
41. 41 Sawada, M., Itoh, Y., Suzumura, A., Marunouchi, T., Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett 160 (1993), 131–134.
42. 42 Sawada, M., Suzumura, A., Marunouchi, T., Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13 (1995), 253–264.
43. 43 Nolan, Y., Maher, F.O., Martin, D.S., Clarke, R.M., Brady, M.T., Bolton, A.E., et al. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem 280 (2005), 9354–9362.
44. 44 de Araujo, E.G., da Silva, G.M., Dos Santos, A.A., Neuronal cell survival: The role of interleukins. Ann N Y Acad Sci 1153 (2009), 57–64.
45. 45 Banks, W.A., Ortiz, L., Plotkin, S.R., Kastin, A.J., Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259 (1991), 988–996.
46. 46 Skurlova, M., Stofkova, A., Jurcovicova, J., Exogenous IL-1beta induces its own expression, but not that of IL-6 in the hypothalamus and activates HPA axis and prolactin release. Endocr Regul 40 (2006), 125–128.
47. 47 Dantzer, R., Cytokine-induced sickness behavior: Where do we stand?. Brain Behav Immun 15 (2001), 7–24.
48. 48 Katila, H., Hanninen, K., Hurme, M., Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4 (1999), 179–181.
49. 49 Piton, A., Michaud, J.L., Peng, H., Aradhya, S., Gauthier, J., Mottron, L., et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 17 (2008), 3965–3974.
50. 50 Handley, M.T., Lian, L.Y., Haynes, L.P., Burgoyne, R.D., Structural and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic spectrum disorder. PloS One, 5, 2010, e10534.
51. 51 Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PloS One, 6, 2011, e20470.
52. 52 Emanuele, E., Orsi, P., Boso, M., Broglia, D., Brondino, N., Barale, F., et al. Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471 (2010), 162–165.
53. 53 Jyonouchi, H., Sun, S., Le, H., Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120 (2001), 170–179.
54. 54 Enstrom, A.M., Onore, C.E., Van de Water, J.A., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24 (2010), 64–71.
55. 55 Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A.E., Pluchino, S., et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31 (2006), 149–160.
56. 56 Araujo, D.M., Cotman, C.W., Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res 600 (1993), 49–55.
57. 57 da Silva, A.G., Campello-Costa, P., Linden, R., Sholl-Franco, A., Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signaling pathways. J Neuroimmunol 196 (2008), 82–93.
58. 58 Sholl-Franco, A., Marques, P.M., Ferreira, C.M., de Araujo, E.G., IL-4 increases GABAergic phenotype in rat retinal cell cultures: Involvement of muscarinic receptors and protein kinase C. J Neuroimmunol 133 (2002), 20–29.
59. 59 Abdallah, M.W., Larsen, N., Grove, J., Norgaard-Pedersen, B., Thorsen, P., Mortensen, E.L., et al. Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 14 (2013), 528–538.
60. 60 Zaghouani, H., Hoeman, C.M., Adkins, B., Neonatal immunity: Faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 30 (2009), 585–591.
61. 61 Rose, S., Lichtenheld, M., Foote, M.R., Adkins, B., Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol 178 (2007), 2667–2678.
62. 62 Skogstrand, K., Hougaard, D.M., Schendel, D.E., Bent, N.P., Svaerke, C., Thorsen, P., Association of preterm birth with sustained postnatal inflammatory response. Obstet Gynecol 111 (2008), 1118–1128.
63. 63 Minagawa, K., Tsuji, Y., Ueda, H., Koyama, K., Tanizawa, K., Okamura, H., et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 17 (2002), 164–170.
64. 64 Lyon, D., Cheng, C.Y., Howland, L., Rattican, D., Jallo, N., Pickler, R., et al. Integrated review of cytokines in maternal, cord, and newborn blood: Part I—associations with preterm birth. Biol Res Nurs 11 (2010), 371–376.
65. 65 Pickler, R., Brown, L., McGrath, J., Lyon, D., Rattican, D., Cheng, C.Y., et al. Integrated review of cytokines in maternal, cord, and newborn blood: Part II—associations with early infection and increased risk of neurologic damage in preterm infants. Biol Res Nurs 11 (2010), 377–386.
66. 66 Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., Van de Water, J., Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch Pediatr Adolesc Med 159 (2005), 151–157.
67. 67 Lyall, K., Ashwood, P., Van de Water, J., Hertz-Picciotto, I., Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord 44 (2014), 1546–1555.